Go back to the public home page
Hello .
 U.S. 


  • News

    • International News

    • Education

    • Environment

    • Healthcare

    • Technology

      • Internet

    • Science

    • Social and Non-Profit

    • Local News

  • Politics
    and Policy

    • Government

    • Politics

    • Local Government

    • International Policy

  • Business
    and Economy

    • Economy

    • Finance

      • Stock Markets

    • Jobs and Labor

    • Company News

    • Industry News

      • Aerospace

      • Agriculture

      • Chemicals

      • Commodities

      • Construction and Engineering

      • Consumer Electronics

      • Defense

      • Energy

        • Nuclear Energy

        • Oil and Gas

        • Renewable Energy

      • Financial Services

        • Banking

        • Insurance

      • Fishing and Aquaculture

      • Manufacturing

      • Information Technology

      • Metals and Mining

      • Pharmaceuticals and Biotechnology

      • Real Estate

      • Professional and Business Services

        • Legal

      • Telecommunications

      • Tobacco

      • Retail

      • Transportation

        • Air Transportation

        • Maritime Transportation

        • Rail Transportation

        • Road Transportation

      • Utilities

      • Forestry and Wood Industry

  • Arts
    and Culture

    • Art

    • Books and Literature

    • Entertainment

      • Cinema

      • Media

        • Radio and Television

      • Music

  • Lifestyle
    and Leisure

    • Automotive

    • Home and Garden

    • Fashion and Luxury

      • Textile and Apparel

    • Food

    • Travel and Hospitality

    • Boating and Yachting


  • Sports

    • Baseball

    • Basketball

    • Boxing

    • Cricket

    • Cycling

    • Football (American)

    • Football (Australian)

    • Football (Soccer)

    • Golf

    • Hockey

    • Racing

    • Rugby

    • Sailing

    • Skiing and Winter Sports

    • Tennis

    • Volleyball

related announcements

News

  • Cytokinetics Incorporated

    Cytokinetics Provides Regulatory Update Related to New Drug Application[...]

  • The Chemours Company

    Chemours Leads Remove2Reclaim Project to Advance Plastic Circularity

  • Draftkings Inc.

    DraftKings Announces Jason Park’s Participation in Upcoming Virtual Event

More

Healthcare

  • BridgeBio Pharma Inc.

    BridgeBio Pharma to Participate in May Investor Events

  • Ensysce Biosciences Inc.

    Investor Presentation dated May 17, 2022 - Form 8-K

  • BOQI International Medical Inc.

    Late Filing Notice (Form NT 10-Q)

More

NGM Biopharmaceuticals Inc.

01/26/2022 | Press release | Distributed by Public on 01/26/2022 18:15

Statement of Changes in Beneficial Ownership (Form 4)

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Sharing and Personal Tools

Please select the service you want to use:

  • Newsvine
  • Digg
  • Delicious
  • StumbleUpon
  • Technorati
  • Buzz
  • Favorites
  • Google Reader

Please use the above public link if you want to share this noodl on another website.

Close

Smartlinks | NGM Biopharmaceuticals Inc. | News | Health | Local News | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Shareholders | Internal Dealings | Financial Services | Investment Funds | Investment Services | Arts and Culture | Public Companies | Biotechnology and Medical Research Companies | Börse Frankfurt | Börse Berlin | Börse München | Börse Stuttgart | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago

 Back

Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact